The risk of dying as a result of alcohol-related causes is greater in persons who have the condition.
This study was the first to use an objective measure to link severity of psoriasis and risk of death.
A new noninvasive approach to assessment for patients receiving methotrexate therapy might reduce the number of liver biopsies.
Clinical trial shows that switching from the infliximab originator to its biosimilar does not compromise safety or effectiveness of treatment.
From skin to joint issues, the list of symptoms associated with psoriatic arthritis is long and not every patient exhibits the same symptoms. In this slideshow, we highlight PsA symptoms and treatments.
In this slideshow, we highlight a Brazilian study that examines the effects of biologics on the three most common psoriasis comorbidities: Metabolic syndrome, cardiovascular disease and fatty liver disease.
In this slideshow, we review the biologics currently approved to treat adults with moderate-to-severe plaque psoriasis and psoriatic arthritis.
The U.S. Food and Drug Administration has approved brodalumab (Siliq) for the treatment of adults and moderate-to-severe plaque psoriasis.
Axial disease seems to increasingly depend on the presence of skin psoriasis and HLA-B*27 alleles, researchers write in ARD.
New treatment guidelines for plaque psoriasis have been issued in the U.S. where 50 percent of patients say they are dissatisfied with treatment.